IPO GMP Today: Dhoot Transmission, LEAP India, Molbio Diagnostics and Milky Mist

Investors tracking IPO GMP today have four major names on their radar: Dhoot Transmission, LEAP India, Molbio Diagnostics and Milky Mist Dairy Food.
As of August 10, 2026, Dhoot Transmission IPO GMP is around ₹259, or 29.7%. LEAP India IPO GMP is around 10%, while Molbio Diagnostics IPO GMP is around 15% to 16%. Milky Mist IPO GMP is ₹26, indicating a premium of about 18.6% over its upper price band.
Among these four IPOs, Dhoot Transmission currently has the highest reported grey market premium.
IPO GMP Today: Dhoot, LEAP India, Molbio and Milky Mist
Here is a quick comparison of the latest GMP figures:
| IPO | Upper Price Band | Latest GMP | GMP % | Indicative Price* |
|---|---|---|---|---|
| Dhoot Transmission IPO | ₹871 | ₹259 | ~29.7% | ₹1,130 |
| LEAP India IPO | ₹159 | ~₹16 | ~10% | ~₹175 |
| Molbio Diagnostics IPO | ₹807 | ~₹120 to ₹130 | ~15% to 16% | ~₹927 to ₹937 |
| Milky Mist IPO | ₹140 | ₹26 | ~18.6% | ₹166 |
*Indicative price is calculated by adding the reported GMP to the upper IPO price. It should not be treated as a guaranteed listing price.
GMP can change several times during the IPO period. It reflects activity in the unofficial grey market and is not regulated by SEBI.
What Is Dhoot Transmission IPO GMP Today?
Dhoot Transmission IPO GMP is around ₹259 as of August 10, 2026. Against the upper IPO price of ₹871, this represents a grey market premium of approximately 29.7%.
Based on the current GMP:
₹871 + ₹259 = ₹1,130
This gives Dhoot Transmission an indicative grey market price of around ₹1,130 per share.
The actual listing price can be higher or lower depending on subscription demand, overall market conditions and investor sentiment closer to listing.
Dhoot Transmission IPO Details
| Particulars | Details |
| IPO opening date | August 10, 2026 |
| IPO closing date | August 12, 2026 |
| Price band | ₹829 to ₹871 |
| Upper price | ₹871 |
| Lot size | 17 shares |
| Issue size | About ₹3,066.89 crore |
| Fresh issue | ₹1,400 crore |
| Latest GMP | Around ₹259 |
| GMP percentage | Around 29.7% |
| Indicative price | Around ₹1,130 |
Dhoot Transmission manufactures electrical and electronic components for the automotive industry. Its products include wiring harnesses and related components used across different vehicle categories.
The IPO includes a fresh issue of ₹1,400 crore, along with an offer for sale by existing shareholders.
What Does Dhoot Transmission IPO GMP Indicate?
The current Dhoot Transmission IPO GMP indicates strong sentiment in the unofficial market.
A ₹259 GMP translates into an implied premium of nearly 30% over the upper issue price. Among the four IPOs covered here, Dhoot Transmission currently has the highest GMP.
That does not automatically make it the best IPO to invest in.
Investors planning to hold the shares beyond listing should also examine the company’s valuation, customer concentration, debt, margins, competitive position and exposure to the automotive cycle.
What Is LEAP India IPO GMP Today?
LEAP India IPO GMP is around 10% as of August 10, 2026.
With an upper IPO price of ₹159, a premium of around ₹16 would put the unofficial implied price near:
₹159 + ₹16 = ₹175
This indicates positive grey market sentiment, although the premium is lower than those currently seen for Dhoot Transmission, Milky Mist and Molbio Diagnostics.
LEAP India IPO Details
| Particulars | Details |
| IPO opening date | August 7, 2026 |
| IPO closing date | August 11, 2026 |
| Price band | ₹151 to ₹159 |
| Upper price | ₹159 |
| Issue size | Around ₹2,480 crore |
| Latest GMP | Around ₹16 |
| GMP percentage | Around 10% |
| Indicative price | Around ₹175 |
LEAP India operates an asset-pooling business. It provides reusable pallets and other supply-chain assets to businesses, helping customers move and store goods without having to own all of these assets themselves.
Is LEAP India IPO GMP Rising or Falling?
LEAP India IPO GMP has fluctuated during the run-up to the issue.
The grey market premium was reported at around 12% near the opening period before moderating to roughly 10%.
This is why looking at the LEAP India IPO GMP trend can be more useful than focusing on one isolated number.
A changing GMP shows how unofficial market sentiment is developing as investors receive more information about subscription levels and broader market conditions.
What Is Molbio Diagnostics IPO GMP Today?
Molbio Diagnostics IPO GMP is around 15% to 16% as of August 10, 2026.
The IPO price band is ₹768 to ₹807 per share.
At the upper price of ₹807, the current GMP indicates an unofficial price of approximately ₹927 to ₹937 per share.
Molbio Diagnostics IPO Details
| Particulars | Details |
| IPO opening date | August 10, 2026 |
| IPO closing date | August 12, 2026 |
| Price band | ₹768 to ₹807 |
| Upper price | ₹807 |
| Issue size | Around ₹940 crore |
| Latest GMP | Around ₹120 to ₹130 |
| GMP percentage | Around 15% to 16% |
| Indicative price | Around ₹927 to ₹937 |
Molbio Diagnostics is a molecular diagnostics company known for its Truenat platform.
The company’s point-of-care molecular diagnostic technology is designed to enable certain tests closer to patients instead of requiring samples to be processed only at large centralized laboratories.
What Is the Molbio Diagnostics IPO GMP Trend?
Molbio Diagnostics IPO GMP has cooled from the higher levels reported before the issue opened.
Grey market reports indicated a premium of around 27% on August 6. By August 10, the premium had moved down to roughly 15% to 16%.
That is a significant change in sentiment.
It does not mean Molbio Diagnostics will necessarily have a weak listing. GMP is unofficial, and actual listing performance depends on demand when the shares begin trading.
For longer-term investors, areas worth examining include revenue growth, profitability, R&D spending, competitive risks and the company’s ability to expand its diagnostic platform.
What Is Milky Mist IPO GMP Today?
Milky Mist IPO GMP is around ₹26 per share as of August 10, 2026.
The Milky Mist Dairy Food IPO has an upper price band of ₹140. A ₹26 GMP therefore represents a premium of approximately:
₹26 ÷ ₹140 × 100 = 18.57%
The implied grey market price is:
₹140 + ₹26 = ₹166
So, the current Milky Mist IPO GMP indicates an unofficial premium of about 18.6%.
Milky Mist IPO Details
| Particulars | Details |
| IPO opening date | August 11, 2026 |
| IPO closing date | August 13, 2026 |
| Price band | ₹133 to ₹140 |
| Upper price | ₹140 |
| Lot size | 107 shares |
| Issue size | Around ₹1,553 crore |
| Fresh issue | Around ₹1,428 crore |
| Offer for sale | Around ₹125 crore |
| Latest GMP | ₹26 |
| GMP percentage | Around 18.6% |
| Indicative price | ₹166 |
The Milky Mist Dairy Food IPO is scheduled to open for subscription on August 11.
Milky Mist operates in the dairy industry and has a portfolio of value-added dairy products, including paneer, curd, cheese, butter, ghee, yogurt and ice cream.
What Should Investors Watch in the Milky Mist IPO?
Milky Mist IPO GMP indicates positive grey market sentiment before the issue opens.
However, brand recognition alone should not determine whether an IPO is attractive.
Investors should also look at:
- Revenue and profit growth
- Operating margins
- Milk procurement costs
- Distribution network
- Debt levels
- Competitive position
- Valuation at the upper price band
- Use of fresh issue proceeds
Input costs are particularly relevant for a dairy company because changes in raw milk prices can affect profitability.
Which IPO Has the Highest GMP Today?
Dhoot Transmission has the highest reported GMP among these four IPOs as of August 10, 2026.
Based on the latest available grey market indications, the ranking is:
- Dhoot Transmission IPO GMP: ~29.7%
- Milky Mist IPO GMP: ~18.6%
- Molbio Diagnostics IPO GMP: ~15% to 16%
- LEAP India IPO GMP: ~10%
Dhoot Transmission currently leads by a clear margin.
Still, this ranking represents grey market sentiment, not the fundamental quality or valuation of each company.
Dhoot Transmission vs LEAP India vs Molbio vs Milky Mist IPO
All four IPOs operate in different industries, which makes a direct comparison based only on GMP less useful.
| IPO | Sector | GMP | Key Factor to Track |
| Dhoot Transmission | Auto components | ~29.7% | Valuation, debt, auto demand |
| LEAP India | Supply-chain assets | ~10% | Asset utilization, valuation |
| Molbio Diagnostics | Molecular diagnostics | ~15% to 16% | Growth, R&D, diagnostics adoption |
| Milky Mist | Dairy products | ~18.6% | Margins, milk costs, valuation |
For investors seeking listing gains, GMP and subscription trends may receive more attention.
For long-term investors, business quality, valuation, cash flow, competitive advantages and earnings growth are generally more important.
What Is IPO GMP?
IPO GMP stands for Initial Public Offering Grey Market Premium. It is the unofficial premium at which IPO shares are discussed or traded before their stock market listing.
For example, suppose an IPO is priced at ₹500 per share and its GMP is ₹100.
Its indicative grey market price would be:
₹500 + ₹100 = ₹600
The GMP percentage would be:
₹100 ÷ ₹500 × 100 = 20%
In simple terms, a positive GMP suggests that unofficial market participants expect the shares to trade above the IPO price.
A negative GMP suggests weaker sentiment.
Neither outcome guarantees what will happen on listing day.
How Is IPO GMP Calculated?
IPO GMP percentage can be calculated using a simple formula:
GMP % = (Grey Market Premium ÷ IPO Upper Price) × 100
For example, Dhoot Transmission has a reported GMP of ₹259 and an upper price of ₹871.
₹259 ÷ ₹871 × 100 = 29.74%
For Milky Mist:
₹26 ÷ ₹140 × 100 = 18.57%
Calculating GMP as a percentage makes it easier to compare IPOs with very different issue prices.
What Is the Estimated IPO Listing Price Based on GMP?
The estimated or indicative price is commonly calculated by adding GMP to the IPO price.
Indicative price = Upper IPO price + GMP
Using the latest reported GMP figures:
| IPO | Upper Price | GMP | Indicative Price |
| Dhoot Transmission | ₹871 | ₹259 | ₹1,130 |
| LEAP India | ₹159 | ~₹16 | ~₹175 |
| Molbio Diagnostics | ₹807 | ~₹120 to ₹130 | ~₹927 to ₹937 |
| Milky Mist | ₹140 | ₹26 | ₹166 |
These are simple calculations based on unofficial GMP figures. They are not predicted or guaranteed listing prices.
Why Does IPO GMP Change Every Day?
IPO GMP changes because expectations and demand in the unofficial market keep changing.
Common factors that can affect GMP include:
- Retail subscription levels
- QIB subscription
- NII subscription
- Anchor investor participation
- Overall stock market sentiment
- Company-specific news
- IPO valuation
- Demand and supply in the grey market
For example, a strong response from institutional investors may improve sentiment around an IPO.
On the other hand, weak subscription numbers or a broader market correction can put pressure on GMP.
This is why searching for IPO GMP today can produce a different figure from what was reported a day earlier.
Is IPO GMP Reliable?
IPO GMP can help measure unofficial market sentiment, but it is not a reliable guarantee of listing gains.
The grey market is outside the regulated stock exchange system. There is no official NSE, BSE or SEBI GMP.
Different grey market trackers may also report slightly different figures at the same time.
GMP is therefore better used as one data point rather than as the sole basis for an IPO investment decision.
Does SEBI Regulate IPO GMP?
No. IPO GMP is not regulated by the Securities and Exchange Board of India (SEBI).
The official IPO process, offer documents and stock exchange disclosures operate within the regulatory framework. Grey market activity takes place outside that formal mechanism.
For verified information about an IPO, investors should rely on the company’s Red Herring Prospectus (RHP), SEBI filings and disclosures made through NSE and BSE.
What Should You Check Apart From IPO GMP?
Before applying for an IPO, consider both the business and the price being asked for it.
1. Valuation
Compare the company’s valuation with listed peers where a meaningful comparison is possible.
A good business can still be expensive at the IPO price.
2. Revenue and profit growth
Check whether revenue and profit have grown consistently over multiple years.
Also look at margins rather than focusing only on headline revenue growth.
3. Cash flow
Profits on paper do not always translate into cash.
Operating cash flow can help investors understand the quality of reported earnings.
4. Debt
Check the company’s borrowings and whether IPO proceeds will be used to repay debt.
Debt levels can have a meaningful impact on risk and future profitability.
5. Fresh issue vs OFS
A fresh issue raises money for the company.
In an offer for sale (OFS), existing shareholders sell their shares, and those proceeds do not go to the company.
Understanding this split can help explain how much new capital the business is actually receiving.
6. IPO subscription status
Subscription levels across QIB, NII and retail categories can provide additional clues about demand.
Institutional participation is worth tracking, but high subscription alone does not guarantee strong post-listing returns.
7. Business-specific risks
Each of these IPOs has different risks.
Dhoot Transmission depends partly on conditions in the automotive industry. LEAP India’s performance is linked to asset utilization and supply-chain demand.
Molbio Diagnostics operates in a technology and R&D-driven healthcare market, while Milky Mist is exposed to milk procurement costs, consumer demand and competition in dairy products.
Which IPO Looks Strongest Based on GMP?
If the comparison is only based on current GMP, Dhoot Transmission has the strongest grey market sentiment at around 29.7%.
Milky Mist follows at around 18.6%, with Molbio Diagnostics at roughly 15% to 16% and LEAP India at around 10%.
But the IPO with the highest GMP is not necessarily the best investment.
Short-term listing sentiment and long-term investment quality are two different things. Investors should consider valuation, financial performance and business risks before making a decision.
FAQs
Q. What is Dhoot Transmission IPO GMP today?
Dhoot Transmission IPO GMP is around ₹259 as of August 10, 2026. Against the upper issue price of ₹871, this represents a premium of approximately 29.7%.
Q. What is Dhoot Transmission IPO expected listing price?
Based on a ₹259 GMP and the upper IPO price of ₹871, the indicative price is around ₹1,130 per share. This is an unofficial calculation and not a guaranteed listing price.
Q. What is LEAP India IPO GMP today?
LEAP India IPO GMP is around ₹16 per share, or approximately 10%, based on its upper issue price of ₹159. This implies an unofficial price near ₹175.
Q. What is LEAP India IPO expected listing price?
Based on a GMP of approximately ₹16, LEAP India’s indicative price is around ₹175 per share. Actual listing performance may differ.
Q. What is Molbio Diagnostics IPO GMP today?
Molbio Diagnostics IPO GMP is around ₹120 to ₹130, or approximately 15% to 16%, as of August 10, 2026. The upper end of its price band is ₹807.
Q. What is Molbio Diagnostics IPO expected listing price?
Based on the current GMP range, Molbio Diagnostics has an indicative price of approximately ₹927 to ₹937 per share.
Q. What is Milky Mist IPO GMP today?
Milky Mist IPO GMP is around ₹26 per share as of August 10, 2026. Compared with the upper IPO price of ₹140, this represents a premium of approximately 18.6%.
Q. What is Milky Mist IPO expected listing price?
Based on the current ₹26 GMP, Milky Mist has an indicative grey market price of around ₹166 per share.
Q. Which IPO has the highest GMP today?
Dhoot Transmission currently has the highest GMP among these four IPOs at approximately 29.7%. Milky Mist follows at about 18.6%, Molbio Diagnostics at 15% to 16%, and LEAP India at around 10%.
Q. Can IPO GMP change after I apply?
Yes. IPO GMP can rise or fall throughout the subscription, allotment and pre-listing period. Applying when GMP is high does not guarantee that the same premium will remain on listing day.
Q. Does high GMP guarantee listing gains?
No. A high GMP indicates positive sentiment in the unofficial market, but it does not guarantee listing gains. Actual listing prices depend on market demand and conditions when trading begins.
Q. Is IPO GMP regulated by SEBI?
No. IPO grey market activity and GMP are unofficial and are not regulated by SEBI. Investors should use official IPO documents and exchange disclosures when evaluating an issue.
Key Takeaways
- Dhoot Transmission IPO GMP is around ₹259, or approximately 29.7%, with an indicative price near ₹1,130.
- LEAP India IPO GMP is around ₹16, or roughly 10%, indicating a price near ₹175.
- Molbio Diagnostics IPO GMP is around ₹120 to ₹130, or approximately 15% to 16%.
- Milky Mist IPO GMP is ₹26, or approximately 18.6%, indicating a price near ₹166.
- Dhoot Transmission currently has the highest reported GMP among the four IPOs.
- GMP changes frequently and is not an official or SEBI-regulated indicator.
- A high GMP does not guarantee listing gains.
- Investors should compare valuation, financials, subscription demand and business risks alongside GMP.
Disclaimer: Grey Market Premium (GMP) is an unofficial market indicator and can change frequently. Indicative prices in this article are simple calculations based on reported GMP and should not be considered guaranteed listing prices. This content is for informational and educational purposes only and does not constitute investment advice.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.





